Vol. 33 No. 2 (2024): Volume 33, No. 2, 2024

Reviews

• FLUID BIOMARKERS IN PARKINSON’S DISEASE

  Anastasia Bougea, Nikolas Papagiannakis, Charikleia-Ilianna Botonaki, Leonidas Stefanis

  • pdf

• TISSUE BIOMARKERS IN PARKINSON’S DISEASE AND ATYPICAL PARKINSONISM

  Athanasia Alexoudi

  • pdf

• BLOOD AND CEREBROSPINAL FLUID BIOMARKERS OF COGNITIVE IMPAIRMENT IN PARKINSON’S DISEASE

  Kanellos Spiliopoulos, George Vavougios, Triantafyllos Doskas

  • pdf

• CSF AND BLOOD BIOMARKERS IN ATYPICAL PARKINSONISM

  Vasileios C. Constantinides, Fotini Boufidou, Leonidas Stefanis, Elisabeth Kapaki

  • pdf

• GENETIC BIOMARKERS IN PARKINSON’S DISEASE

  Georgia Xiromerisiou, Chrysoula Marogianni, Olga Sinani

  • pdf

• IMAGING BIOMARKERS IN PARKINSON’S DISEASE

  Georgios A. Tagaris

  • pdf

• NEUROPHYSIOLOGICAL BIOMARKERS AT CORTICAL AND BASAL GANGLIA LEVELS IN PARKINSON’S DISEASE

  Athanasios Leonardos, Pantelis Stathis, Stergios-Stylianos Gatzonis

  • pdf

• WEARABLE DEVICES AND SMARTPHONES FOR PARKINSON’S DISEASE DIAGNOSIS

  Sevasti Bostantjopoulou, Zoe Katsarou, Ioannis Dagklis

  • pdf

• UTILIZING DIGITAL BIOMARKERS FOR THE MONITORING AND MANAGEMENT OF PARKINSON DISEASE

  Foivos S. Kanellos, Konstantinos I. Tsamis, Dimitrios Chatzistefanidis, Nikolaos Kostikis, Spyridon Konitsiotis

  • pdf

• CLINICAL BIOMARKERS IN PARKINSON’S DISEASE AND ATYPICAL PARKINSONISM

  Maria Chondrogiorgi, Spyridon Konitsiotis

  • pdf